CareDx, Inc. (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
47.07
+0.38 (0.81%)
Aug 10, 2026, 4:00 PM EDT - Market closed
CareDx Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 111.01 | -21.35 | 52.55 | -190.28 | -76.61 | -30.66 |
Depreciation & Amortization | 19.79 | 20.42 | 19.76 | 19.82 | 16.01 | 11.89 |
Stock-Based Compensation | 36.97 | 34.86 | 66.41 | 49.09 | 46.55 | 36.08 |
Other Adjustments | 0.4 | 4.28 | 1.64 | -3.61 | 3.03 | 4.37 |
Change in Receivables | 24.82 | 22.52 | -13.74 | 16.02 | -6.66 | -24.42 |
Changes in Inventories | 3.71 | -4.96 | -1.02 | 0.05 | -2.86 | -6.93 |
Changes in Accounts Payable | 0.04 | 0.81 | -5.11 | 2.9 | -2.05 | 1.79 |
Changes in Accrued Expenses | 20.2 | -5.71 | -76.99 | 92.26 | 2.08 | 18.21 |
Changes in Income Taxes Payable | - | 0.02 | -0.19 | 0.57 | -0.22 | -1.38 |
Changes in Unearned Revenue | -0.17 | - | - | - | - | -20.5 |
Changes in Other Operating Activities | -14.63 | -10.41 | -5.26 | -3.65 | -4.51 | -7.75 |
Operating Cash Flow | 93.66 | 42.03 | 38.05 | -18.39 | -25.24 | -19.29 |
Operating Cash Flow Growth | 428.48% | 10.47% | - | - | - | - |
Capital Expenditures | -8.95 | -5.91 | -6.48 | -8.34 | -21.23 | -13.56 |
Purchases of Intangible Assets | - | -0.68 | - | -0.9 | -3.1 | -6.7 |
Purchases of Investments | -118.5 | -145.93 | -160.92 | -202.13 | -315.15 | -5.5 |
Proceeds from Sale of Investments | 119.78 | 154.67 | 166.92 | 258.5 | 111.59 | 88.91 |
Cash Acquisitions | - | - | - | -6.68 | -0.61 | -15.43 |
Investing Cash Flow | 269.08 | 2.16 | -0.48 | 40.45 | -228.5 | 47.71 |
Long-Term Debt Repaid | - | - | - | - | - | -0.07 |
Net Long-Term Debt Issued (Repaid) | - | - | - | - | - | -0.07 |
Issuance of Common Stock | 5.5 | 8 | 10.33 | 1.62 | 4.67 | 203.77 |
Repurchase of Common Stock | -61.35 | -99.89 | -10.61 | -30.6 | -6.58 | -18.07 |
Net Common Stock Issued (Repurchased) | -55.85 | -91.89 | -0.28 | -28.98 | -1.91 | 185.71 |
Other Financing Activities | -1.5 | -1.5 | -5.33 | -0.63 | -2.63 | - |
Financing Cash Flow | -57.35 | -93.39 | -5.61 | -29.61 | -4.54 | 185.64 |
Foreign Exchange Rate Adjustments | 0 | -0.09 | 0.53 | -0.11 | 0.02 | -0.3 |
Net Cash Flow | 305.39 | -49.29 | 32.49 | -7.66 | -258.25 | 213.76 |
Free Cash Flow | 84.71 | 36.12 | 31.56 | -26.73 | -46.47 | -32.85 |
Free Cash Flow Growth | 613.13% | 14.43% | - | - | - | - |
FCF Margin | 18.49% | 9.51% | 9.46% | -9.54% | -14.44% | -11.08% |
Free Cash Flow Per Share | 1.60 | 0.68 | 0.56 | -0.50 | -0.87 | -0.63 |
Levered Free Cash Flow | 26.84 | -27.11 | -22.74 | -86.67 | -89.4 | -48.96 |
Unlevered Free Cash Flow | 19.74 | -36.93 | -34.77 | -99.9 | -90.4 | -46.63 |